SF3131 (Legislative Session 94 (2025-2026))

Commissioner of human services direction to establish a prescription drug purchasing program

Related bill: HF1093

AI Generated Summary

Purpose of the Bill

This bill aims to create a prescription drug purchasing program in Minnesota. The goal is to purchase prescription drugs at the lowest possible prices for individuals enrolled in Medical Assistance and MinnesotaCare.

Main Provisions

  • Establishment: The program will be overseen by Minnesota's commissioner of human services, targeting Medical Assistance and MinnesotaCare enrollees who are part of fee-for-service and managed care delivery systems.

  • Commissioner's Duties:

    • The commissioner will be responsible for obtaining prescription drugs at low prices.
    • The program is designed to promote health by providing discounted medication and coordinating comprehensive prescription benefits.
    • A list of the most effective prescription drugs at the best prices will be maintained.
  • Program Authority:

    • The commissioner has the authority, in consultation with the Formulary Committee, to adopt a preferred drug list.
    • Engaging in price negotiations with drug manufacturers for discounts and rebates.
    • Development and management of a drug formulary for the program.
  • Pharmacy Participation:

    • The commissioner will set participation terms for pharmacies.
    • All pharmacies participating as medical assistance providers, along with any willing and licensed pharmacies, can join the program under these terms.
  • Federal Approval:

    • The program will seek necessary federal approvals to be implemented.

Significant Changes

This bill introduces a structured program aimed at reducing prescription drug costs through statewide purchasing and negotiation efforts, which could result in more affordable access to medications for eligible Minnesota residents.

Relevant Terms

  • Prescription drug purchasing
  • Medical Assistance
  • MinnesotaCare
  • Fee-for-service
  • Managed care
  • Preferred drug list
  • Formulary
  • Price negotiations
  • Prescription drug manufacturers
  • Drug formulary
  • Federal approvals

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 31, 2025SenateFloorActionIntroduction and first reading
March 31, 2025SenateFloorActionReferred toHealth and Human Services